What is it about?
This was a pioneering study exploring an individualized tailor prognosis calculator exhibited accurate continuous range of recurrence free survival probability algorithm for early HCC within the Milan criteria (MC) with composite multi-parametric evaluations including different curative treatment allocation for different tumor status and liver function.
Featured Image
Why is it important?
Accurate prediction of recurrece free survival prediction algorithm consisting of different treatment allocation for different tumor status and liver function in any individual HCC patient within the MC can be objectivized in a novel website-based prognosis calculator and showed feasibility for simpler use of quick assessment of HCC specific outcome for therapeutic alternatives.
Perspectives
Our individualized tailored prognosis calculator for the prediction of recurrence free survival is likely to be important when updating the treatment guidelines for early HCC within the MC. It showed potential feasibility of simpler use to assess the treatment allocation of the curative therapy and assist with the MDT clinical strategy decision making.
Wei Lu
Tianjin Medical University Cancer Institute and Hospital
Read the Original
This page is a summary of: Individualised tailored assessment of therapeutic alternatives for HCC patients within the Milan criteria, Gut, November 2019, BMJ,
DOI: 10.1136/gutjnl-2019-320073.
You can read the full text:
Resources
Contributors
The following have contributed to this page
